At a glance
- Originator Kunming Pharmaceutical
- Class Anthelmintics; Antifungals; Antimalarials; Antineoplastics; Antiprotozoals; Artemisinins; Fluorenes; Skin disorder therapies; Small molecules
- Mechanism of Action Angiogenesis inhibitors; Carrier protein inhibitors; Mitochondrial protein inhibitors; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Malaria
- No development reported Schistosomiasis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Schistosomiasis in Ivory Coast (PO)
- 02 Jun 2000 Investigation in Schistosomiasis in Ivory Coast (PO)
- 02 Jun 2000 A clinical study evaluating artemether for the prevention of schistosomiasis has been added to the therapeutic trials section